| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $1.8M | -19.6% |
| SG&A Expense | $8.8M | +77.3% |
| Operating Income | -$10.6M | -47.3% |
| Interest Expense | $5K | -99.8% |
| Net Income | -$14.8M | -44.7% |
| EPS (Basic) | -$1.69 | -10.5% |
| EPS (Diluted) | -$1.69 | -10.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | +328.3% |
| Short-term Investments | $0 | — |
| Current Assets | $2.2M | +396.4% |
| Total Assets | $2.2M | +239.7% |
| Current Liabilities | $2.1M | -80.5% |
| Total Liabilities | $2.1M | -80.5% |
| Stockholders' Equity | $109K | +101.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | -10.1% |
| Financing Cash Flow | $7.5M | +55.8% |